Laserfiche WebLink
address mental health needs in young people that (when not properly addressed) <br />increase the risk of opioid or other drug misuse. <br />H. PREVENT OVERDOSE DEATHS AND OTHER HARMS <br />Support efforts to prevent or reduce overdose deaths or other opioid-related harms through <br />evidence-based, evidence-informed, or promising programs or strategies that may include, <br />but are not limited to, the following: <br />1. Increase availability and distribution of naloxone and other drugs that treat overdoses <br />for first responders, overdose patients, opioid users, families and friends of opioid <br />users, schools, community navigators and outreach workers, drug offenders upon <br />release from jail/prison, or other members of the general public. <br />2. Provision by public health entities of free naloxone to anyone in the community, <br />including but not limited to provision of intra-nasal naloxone in settings where other <br />options are not available or allowed. <br />3. Training and education regarding naloxone and other drugs that treat overdoses for <br />first responders, overdose patients, patients taking opioids, families, schools, and <br />other members of the general public. <br />4. Enable school nurses and other school staff to respond to opioid overdoses, and <br />provide them with naloxone, training, and support. <br />5. Expand, improve, or develop data tracking software and applications for <br />overdoses/naloxone revivals. <br />6. Public education relating to emergency responses to overdoses. <br />7. Public education relating to immunity and Good Samaritan laws. <br />8. Educate first responders regarding the existence and operation of immunity and Good <br />Samaritan laws. <br />9. Expand access to testing and treatment for infectious diseases such as HIV and <br />Hepatitis C resulting from intravenous opioid use. <br />10. Support mobile units that offer or provide referrals to treatment, recovery supports, <br />health care, or other appropriate services to persons that use opioids or persons with <br />OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction. <br />11. Provide training in treatment and recovery strategies to health care providers, <br />students, peer recovery coaches, recovery outreach specialists, or other professionals <br />that provide care to persons who use opioids or persons with OUD and any co- <br />occurring SUD/MH conditions, co-usage, and/or co-addiction. <br />12. Support screening for fentanyl in routine clinical toxicology testing. <br />9